Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302).

Glover, J M

Phase I safety and pharmacokinetic profile of an intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302). [electronic resource] - The Journal of pharmacology and experimental therapeutics Sep 1997 - 1173-80 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase I; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0022-3565


Adult
Double-Blind Method
Humans
Intercellular Adhesion Molecule-1--genetics
Male
Oligodeoxyribonucleotides, Antisense
Oligonucleotides, Antisense--adverse effects
Phosphorothioate Oligonucleotides
Thionucleotides--adverse effects